Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned

Antibody –drug conjugates (ADCs) have emerged as a novel therapeutic strategy that has successfully reached patient treatment in different clinical scenarios. ADCs are formed by an antibody against a specific t...

Source: Journal of Hematology and Oncology - December 12, 2023 Category: Hematology Authors: Alfonso L ópez de Sá, Cristina Díaz-Tejeiro, Elisa Poyatos-Racionero, Cristina Nieto-Jiménez, Lucía Paniagua-Herranz, Adrián Sanvicente, Emiliano Calvo, Pedro Pérez-Segura, Víctor Moreno, Francisco Moris and Alberto Ocana Tags: Review Source Type: research